Área científica IDIAP Jordi Gol, Barcelona, España.
Arch Bronconeumol. 2011 May;47(5):226-33. doi: 10.1016/j.arbres.2010.10.009. Epub 2011 Feb 4.
Several studies have approached the use of spirometry in the treatment of chronic obstructive pulmonary disease (COPD) in Primary Care (PC), but few have analysed its impact on the treatment of the patient with COPD.
To evaluate the use of spirometry in the diagnosis and follow-up of COPD patients in PC, and its impact on treatment. To analyse the variation in the performing of spirometry between PC centres.
A multicentre, observational and cross-sectional study of COPD patients seen in PC in Catalonia (Spain) during 2004-2005. A multilevel logistic regression model was used to identify factors associated with having spirometry and to determine the variation between the different centres.
Twenty-one centres which included 801 patients took part. Only 53.2% of them had a diagnostic spirometer available and the mean (standard deviation) FEV1(%) was 54.8% (18%). The registers of smoking habits, complementary tests and spirometry follow-up were more common among patients who had a diagnostic spirometry available compared to those who did not. No statistically significant differences were found as regards demographic, clinical, treatment and quality of life variables between patients with and without follow-up spirometry. Significant variation was observed in the percentage of diagnostic spirometries between different PC centres (variance=0.217; p<0.001).
Spirometry is underused in PC and performing it during follow-up is not associated to the different treatments received, or with a more complete approach to the disease. There is significant variation in the performing of spirometry among PC centres.
多项研究探讨了在基层医疗保健(PC)中使用肺量计来治疗慢性阻塞性肺疾病(COPD),但很少有研究分析其对 COPD 患者治疗的影响。
评估肺量计在 PC 中 COPD 患者的诊断和随访中的使用情况及其对治疗的影响。分析 PC 中心之间肺量计检测的差异。
这是一项在 2004-2005 年期间在西班牙加泰罗尼亚地区的 PC 中观察 COPD 患者的多中心、观察性、横断面研究。采用多水平逻辑回归模型来确定与进行肺量计检测相关的因素,并确定不同中心之间的差异。
有 21 个中心参与了研究,共纳入 801 名患者。仅有 53.2%的中心配备有诊断性肺量计,平均(标准差)FEV1(%)为 54.8%(18%)。与没有诊断性肺量计的患者相比,有诊断性肺量计的患者的吸烟习惯、补充检查和肺量计随访记录更为常见。在患者的人口统计学、临床、治疗和生活质量变量方面,有无随访肺量计的患者之间未发现统计学差异。不同 PC 中心之间的诊断性肺量计检测百分比存在显著差异(方差=0.217;p<0.001)。
肺量计在 PC 中的使用不足,在随访中进行肺量计检测与所接受的不同治疗或更全面的疾病管理方法无关。PC 中心之间在进行肺量计检测方面存在显著差异。